Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT00725075
Official study titleA Multi-center, Double-blind, Flexible-dose Efficacy Trial With Org 25935 Versus Placebo as add-on Therapy in Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia Treated With a Stable Dose of a Second Generation Antipsychotic (GIANT)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–55
- Countries
- Sponsor
- Merck Sharp & Dohme LLC
CompletedNCT02577575
Official study titleThe Effects of Oxytocin on Social Cognition in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT02567032
Official study titleMechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - Behavioral
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT02566356
Official study titleMechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - fMRI
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT02621983
This study has finished and is no longer accepting participants.
In DecaturSchizophreniaBehavioural studyAges 18–70
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
TerminatedNCT00794963
Official study titleAggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for Schizophrenia
This study ended early.
In Glen OaksSchizophreniaMedication studyAges 19–79
- Countries
- United States
- Sponsor
- Northwell Health
CompletedNCT00280813
Official study titleTreatment of Alcohol Use Disorders in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimoreSchizophreniaBehavioural studyAges 22–60
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
WithdrawnNCT01567124
Official study titleA Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
This study was withdrawn before enrollment.
Multiple locations, including BallaratSchizophreniaMedication studyAges 18–65
- Countries
- Australia
- Sponsor
- Baker Heart and Diabetes Institute
CompletedISRCTN68824876
This study has finished and is no longer accepting participants.
Multiple locations, including LondonSchizophreniaDrug
- Countries
- United Kingdom
- Sponsor
- Imperial College London
CompletedNCT00728195
What is this study about?This study evaluated the safety and effectiveness of JNJ-37822681 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BurgasSchizophreniaMedication studyAges 18–65
- Countries
- Bulgaria, Estonia, Lithuania, + 7 others
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT01009047
Official study titleA Randomized, Multicenter, Double-Blind, Active-Controlled, Flexible-Dose, Parallel-Group Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Symptoms of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age
This study has finished and is no longer accepting participants.
Multiple locations, including DothanSchizophreniaMedication studyAges 12–17
- Countries
- United States, India, Romania, + 4 others
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT00524043
What is this study about?Researchers compared Paliperidone ER and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18+
- Countries
- United States, India, Taiwan
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
